Showing results (71-80 of 125) with videos related to

Sort By:
Pageof 13
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 14, 2019
Brain and lesion segmentation in multiple sclerosis using fully convolutional neural networks: A large-scale studyRefaat E Gabr, Ivan Coronado, Melvin Robinson, et al.
Multiple Sclerosis and Related Disorders|May 22, 2022
The validity, responsiveness, and score interpretation of the PROMISnq Physical Function - Multiple Sclerosis 15a short form in multiple sclerosisPaul Kamudoni, Dagmar Amtmann, Jeffrey Johns, et al.
Neurodegenerative Disease Management|July 26, 2024
People with multiple sclerosis help design a tool to measure physical functioning and how it affects their daily lives: a plain language summaryPaul Kamudoni, Dagmar Amtmann, Jeffrey Johns, et al.
AJNR. American Journal of Neuroradiology|February 6, 2002
Quantitative functional MR imaging of the visual cortex at 1.5 T as a function of luminance contrast in healthy volunteers and patients with multiple sclerosisScott H Faro, Feroze B Mohamed, Joseph I Tracy, et al.
International Immunology|January 8, 2011
Impaired IFN-γ production and proliferation of NK cells in multiple sclerosisAnna Lünemann, Björn Tackenberg, Tracy DeAngelis, et al.
Orphanet Journal of Rare Diseases|March 26, 2013
Atypical Chédiak-Higashi syndrome with attenuated phenotype: three adult siblings homozygous for a novel LYST deletion and with neurodegenerative diseaseJames D Weisfeld-Adams, Lakshmi Mehta, Janet C Rucker, et al.
Multiple Sclerosis and Related Disorders|April 21, 2015
Human placenta-derived cells (PDA-001) for the treatment of adults with multiple sclerosis: a randomized, placebo-controlled, multiple-dose studyFred D Lublin, James D Bowen, John Huddlestone, et al.
Human Brain Mapping|June 23, 2015
Effect of in-painting on cortical thickness measurements in multiple sclerosis: A large cohort studyKoushik A Govindarajan, Sushmita Datta, Khader M Hasan, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 4, 2023
Serum neurofilament light-chain levels and long-term treatment outcomes in relapsing-remitting multiple sclerosis patients: A post hoc analysis of the randomized CombiRx trialGary Cutter, Richard A Rudick, Carl de Moor, et al.
Multiple Sclerosis and Related Disorders|May 28, 2023
Effects of baseline age and disease duration on the efficacy and safety of siponimod in patients with active SPMS: Post hoc analyses from the EXPAND studyLe H Hua, Amit Bar-Or, Stanley L Cohan, et al.
Pageof 13